Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases.
Phase of Trial: Phase I/II
Latest Information Update: 16 Jun 2011
At a glance
- Drugs Melphalan (Primary) ; Oxaliplatin (Primary)
- Indications Cancer metastases; Liver cancer
- Focus Adverse reactions; Pharmacokinetics
- 16 Jun 2011 New trial record